drugset / Trial / NCT02183701

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

NCT02183701

Phase 3 Completed 715 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

The general aim and clinical objective of this trial is to determine the effect of telmisartan 80 mg compared to losartan 50 mg + HCTZ (Hydrochlorothiazide) 12.5 mg on reduction of blood pressure (BP) in patients with mild to moderate hypertension as assessed by 24 hour Ambulatory Blood Pressure Monitoring (ABPM) and trough sitting BP cuff measurements at the end of the treatment.

Timeline

Start
1998-04
Primary completion
1998-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrochlorothiazide Unknown 12.5 mg
Comparator Losartan Other / unclassified 50 mg
Subject Telmisartan Other / unclassified 80 mg

Indications